Massachusetts General Hospital
Fourth COVID-19 vaccine dose reduces severe infection risk by 65% in patients with SARDs
SAN DIEGO — A fourth COVID-19 mRNA vaccine dose reduces the risk for severe infection by 65% in patients with systemic autoimmune rheumatic disease using immunomodulators, according to data presented at ACR Convergence 2023.
Conversations on Immunotherapy with Kerry Reynolds, MD
In this episode, host Shikha Jain, MD, speaks with Kerry Reynolds, MD, about immunotherapy-related adverse events, creating educational resources on immunotherapy management and more.
Pitavastatin lowers plaque volume, progression in lower-risk patients with HIV
PHILADELPHIA — Pitavastatin lowered noncalcified plaque volume and reduced risk for plaque progression compared with placebo in patients with HIV at low to moderate risk for CVD, according to new data from the REPRIEVE trial.
Women at significant risk for urinary, genital infections while using SGLT2i
SAN DIEGO — Women with autoimmune and rheumatic conditions are at a significant risk for adverse events during treatment with sodium glucose cotransporter 2 inhibitors, according to data presented at ACR Convergence 2023.
VIDEO: 3D, 4D imaging expand understanding of trochlear dysplasia, patellar instability
In this video, Miho J. Tanaka, MD, PhD, discussed the use of 3D and 4D imaging to better understand the role of trochlear dysplasia for surgical decision-making in patients with patellar instability.
High-dose inhaled nitric oxide improves oxygenation in COVID-19 pneumonia
Adults on mechanical ventilation for COVID-19 pneumonia showed improvements in oxygenation with high-dose inhaled nitric oxide, according to results published in American Journal of Respiratory and Critical Care Medicine.
Datopotamab deruxtecan extends PFS vs. chemotherapy in advanced breast cancer
MADRID — Datopotamab deruxtecan extended PFS compared with chemotherapy for patients with previously treated inoperable or metastatic hormone receptor-positive, HER2-negative breast cancer, according to study results presented at ESMO Congress.
Combination may be ‘new standard’ in EGFR-mutant non-small cell lung cancer
MADRID — The combination of amivantamab and lazertinib improved PFS compared with osimertinib as first-line treatment for EGFR-mutated advanced non-small cell lung cancer, according to study results presented at ESMO Congress.
VIDEO: Use BMI as a screening tool, not a diagnostic tool
DALLAS — In this Healio video exclusive, Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS, discusses cultural competency with regard to obesity care.
Cancer Early Detection with Douglas Micalizzi, MD, & Lecia Sequist, MD
In this episode, host Shikha Jain, MD, speaks with Douglas Micalizzi, MD, and Lecia Sequist, MD, about adopting novel technologies for early detection, public perception of prevention screening and more.